GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » EV-to-FCF

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) EV-to-FCF : -13.67 (As of Apr. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Enterprise Value is E£4,072 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was E£-298 Mil. Therefore, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF for today is -13.67.

The historical rank and industry rank for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF or its related term are showing as below:

CAI:RMDA' s EV-to-FCF Range Over the Past 10 Years
Min: -493.02   Med: -13.69   Max: 943.92
Current: -15.02

During the past 6 years, the highest EV-to-FCF of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents was 943.92. The lowest was -493.02. And the median was -13.69.

CAI:RMDA's EV-to-FCF is ranked worse than
100% of 509 companies
in the Drug Manufacturers industry
Industry Median: 21.93 vs CAI:RMDA: -15.02

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's stock price is E£2.22. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was E£0.149. Therefore, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's PE Ratio for today is 14.90.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-FCF Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-FCF Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -96.63 -9.18 880.15 -34.20 -10.86

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.20 -14.25 -9.52 -6.88 -10.86

Competitive Comparison of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF falls into.



Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-FCF Calculation

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4072.451/-297.986
=-13.67

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current Enterprise Value is E£4,072 Mil.
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-298 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents  (CAI:RMDA) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.22/0.149
=14.90

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's share price for today is E£2.22.
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.149.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines